Europe‘s flagship biotech event is set to unite over 4,000 global industry leaders, investors, and innovators at Excel London on 9โ10 June 2026, reinforcing the UK capital’s position as a world-leading life sciences hub.
February 2026- The London Biotechnology Show 2026 will take place on 9 and 10 June 2026 at Excel London, Royal Victoria Dock, London E16 1XL. Organized by Valiant Business Media Ltd, the two day event is recognized as one of Europeโs leading biotechnology conferences and exhibitions, bringing together professionals from across the global biotech ecosystem.
Also read:Dubai Nurse Welcomes Triplets After Years of Hope
The 2026 edition is expected to welcome more than 4,000 attendees, over 150 exhibitors and more than 100 expert speakers representing biopharmaceuticals, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical research and biomanufacturing.
The conference programme will feature keynote addresses, panel discussions and interactive workshops highlighting the latest advancements in red biotechnology and life sciences innovation. The event will also host the Global Biotech Awards, recognising excellence, research leadership and industry innovation. Participants including biotechnology companies, pharmaceutical executives, medtech innovators, investors, researchers and policymakers will benefit from structured networking sessions designed to encourage cross border collaboration and global investment opportunities.
Click here to join our WhatsApp channel here
MedEdge MEA, Media Partner
MedEdge MEA is a leading healthcare and life sciences media platform serving the Middle East and Africa. Published by Two Point Five Media FZCO and headquartered in the UAE, the publication delivers trusted healthcare news, expert interviews, clinical research insights and in depth analysis across medicine, biotechnology, digital health and medical innovation. With strong readership across the GCC, MENA and African markets, MedEdge MEA connects healthcare leaders, policymakers, researchers and industry stakeholders through authoritative journalism and strategic event partnerships. As an official media partner of the London Biotechnology Show 2026, MedEdge MEA continues to strengthen global dialogue in biotechnology and support knowledge exchange across emerging and established healthcare markets.
